RESUMEN
Obese asthma presents with inherent hyperresponsiveness to methacholine or augmented allergen-driven allergic asthma, with an even greater magnitude of methacholine hyperresponsiveness. These physiologic parameters and accompanying obese asthma symptoms can be reduced by successful weight loss, yet the underlying mechanisms remain incompletely understood. We implemented mouse models of diet-induced obesity, dietary and surgical weight loss, and environmental allergen exposure to examine the mechanisms and mediators of inherent and allergic obese asthma. We report that the methacholine hyperresponsiveness in these models of inherent obese asthma and obese allergic asthma manifests in distinct anatomical compartments but that both are amenable to interventions that induce substantial weight loss. The inherent obese asthma phenotype, with characteristic increases in distal airspace tissue resistance and tissue elastance, is associated with elevated proinflammatory cytokines that are reduced with dietary weight loss. Surprisingly, bariatric surgery-induced weight loss further elevates these cytokines while reducing methacholine responsiveness to levels similar to those in lean mice or in formerly obese mice rendered lean through dietary intervention. In contrast, the obese allergic asthma phenotype, with characteristic increases in central airway resistance, is not associated with increased adaptive immune responses, yet diet-induced weight loss reduces methacholine hyperresponsiveness without altering immunological variables. Diet-induced weight loss is effective in models of both inherent and allergic obese asthma, and our examination of the fecal microbiome revealed that the obesogenic Firmicutes/Bacteroidetes ratio was normalized after diet-induced weight loss. Our results suggest that structural, immunological, and microbiological factors contribute to the manifold presentations of obese asthma.
Asunto(s)
Asma/complicaciones , Hiperreactividad Bronquial/complicaciones , Hipersensibilidad/complicaciones , Obesidad/inducido químicamente , Obesidad/complicaciones , Pérdida de Peso , Animales , Asma/patología , Bacterias/metabolismo , Cirugía Bariátrica , Hiperreactividad Bronquial/patología , Citocinas/metabolismo , Dieta , Modelos Animales de Enfermedad , Hipersensibilidad/patología , Mediadores de Inflamación/metabolismo , Intestinos/microbiología , Intestinos/patología , Masculino , Cloruro de Metacolina , Ratones Endogámicos C57BL , Ratones ObesosRESUMEN
Before breath-based diagnostics for lung infections can be implemented in the clinic, it is necessary to understand how the breath volatiles change during the course of infection, and ideally, to identify a core set of breath markers that can be used to diagnose the pathogen at any point during the infection. In the study presented here, we use secondary electrospray ionization-mass spectrometry (SESI-MS) to characterize the breathprint of Pseudomonas aeruginosa and Staphylococcus aureus lung infections in a murine model over a period of 120 h, with a total of 86 mice in the study. Using partial least squares-discriminant analysis (PLS-DA) to evaluate the time-course data, we were able to show that SESI-MS breathprinting can be used to robustly classify acute P. aeruginosa and S. aureus mouse lung infections at any time during the 120 h infection/clearance process. The variable importance plot from PLS indicates that multiple peaks from the SESI-MS breathprints are required for discriminating the bacterial infections. Therefore, by utilizing the entire breathprint rather than single biomarkers, infectious agents can be diagnosed by SESI-MS independent of when during the infection breath is tested.